The impact of (177)Lu-octreotide therapy on (99m)Tc-MAG3 clearance is not predictive for late nephropathy

Peptide Receptor Radionuclide Therapy (PRRT) for the treatment of neuroendocrine tumors may lead to kidney deterioration. This study aimed to evaluate the suitability of (99m)Tc-mercaptoacetyltriglycine ((99m)Tc­-MAG3) clearance for the early detection of PRRT-induced changes on tubular extraction (...

Descripción completa

Detalles Bibliográficos
Autores principales: Werner, Rudolf A., Beykan, Seval, Higuchi, Takahiro, Lückerath, Katharina, Weich, Alexander, Scheurlen, Michael, Bluemel, Christina, Herrmann, Ken, Buck, Andreas K., Lassmann, Michael, Lapa, Constantin, Hänscheid, Heribert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173054/
https://www.ncbi.nlm.nih.gov/pubmed/27259246
http://dx.doi.org/10.18632/oncotarget.9775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5173054/
https://www.ncbi.nlm.nih.gov/pubmed/27259246
http://dx.doi.org/10.18632/oncotarget.9775

Ejemplares similares